PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

PAR, some place in QLD and the (magical) possible pathway..., page-2

  1. 1,142 Posts.
    lightbulb Created with Sketch. 201
    as always great research.

    Yep I think you are definitely on the right track with RRV and ChikV. The peer reviewed paper should be out this quarter.

    the phase 2 trial had some really positive outcomes.

    hopefully DoD sponsors Phase 3 trial and there is an accelerated pathway.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.